[ad_1]
Some of the major players operating in the tubeless insulin pump industry are Roche Diabetes Care, Insulet Corporation, Terumo Corporation, and Medtrum Technologies.
SELBYVILLE, Del., May 24, 2022 /PRNewswire/ — The tubeless insulin pump market value is projected to reach USD 6.2 billion by 2030, according to a new research report by Global Market Insights Inc. Increasing disease burden along with incremental healthcare expenses associated with diabetes is likely to impel the market statistics.
Adoption of supportive initiatives and implementation of facilitative policies by the governing agencies & public organizations to drive awareness regarding diabetes and to promote access to affordable diabetes management will drive the industry expansion. In the US, the Centers for Disease Control and Prevention (CDC) initiated the National Diabetes Prevention Program (National DPP). This program is a collaborative effort among public and private organizations aiming to reduce or limit the prevalence of type 2 diabetes. This program, 3 years after its inception, indicated that participants in the DPP program documented reduced chance of developing type 2 diabetes by 58% as compared to the participants that were given a placebo.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2032
Significant portion of the diabetes population uses insulin pumps for…
Full story available on Benzinga.com
[ad_2]
Source link
